AKTX

Akari Therapeutics Plc ADR

May 15 • 04:00PM ET

3.49

-0.21 -5.68 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: MREO LRMR OCGN BDTX VNDA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-19.27	Insider Own	0.40%	Shs Outstand	45.27M	Perf Week	-44.16%
Market Cap	157.99M	Forward P/E	-	EPS next Y	-4.68	Insider Trans	0.00%	Shs Float	45.09M	Perf Month	-31.84%
Enterprise Value	153.48M	PEG	-	EPS next Q	-1.33	Inst Own	0.23%	Short Float	0.04%	Perf Quarter	-62.55%
Income	-17.29M	P/S	-	EPS this Y	72.10%	Inst Trans	336.95%	Short Ratio	0.48	Perf Half Y	-83.93%
Sales	0.00M	P/B	5.58	EPS next Y	18.89%	ROA	-35.05%	Short Interest	0.02M	Perf YTD	-69.81%
Book/sh	0.63	P/C	30.04	EPS next 5Y	32.82%	ROE	-68.39%	52W High	56.80 -93.86%	Perf Year	-93.39%
Cash/sh	0.12	P/FCF	-	EPS past 3/5Y	- -	ROIC	-61.03%	52W Low	3.02 15.75%	Perf 3Y	-97.63%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	31.19% 17.00%	Perf 5Y	-99.77%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	13.85%	Oper. Margin	-	ATR (14)	0.80	Perf 10Y	-99.97%
Dividend Ex-Date	-	Quick Ratio	0.44	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	36.11	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.44	EPS Q/Q	-	SMA20	-33.93%	Beta	0.58	Target Price	33.50
Payout	-	Debt/Eq	0.03	Sales Q/Q	-	SMA50	-39.85%	Rel Volume	0.39	Prev Close	3.70
Employees	6	LT Debt/Eq	0.00	Earnings	Apr 07	SMA200	-81.45%	Avg Volume	33.80K	Price	3.49
IPO	May 07, 2013	Option/Short	No / Yes	EPS/Sales Surpr.	-66.11% -	Trades		Volume	13,242	Change	-5.68%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)